Video

Institutional Perspectives in Rheumatology: ANCA-associated Vasculitis

Dr. Kenneth J. Warrington led the panel in discussing various topics in rheumatology.

Recently, Kenneth J. Warrington, MD, Mayo Clinic, chaired a panel of rheumatologists to discuss the current state of vasculitis care.

The program, called Institutional Perspectives in Rheumatology: ANCA-associated Vasculitis, is part of HCPLive’s® State of the Science series.

Joining Warrington on the March 22 panel was 2 other rheumatologists from the Mayo Clinic.

Matthew J. Koster, MD, kicked off the program with a discussion on the burden of ANCA-associated vasculitis (AAV). Koster was followed by Tanaz A. Kermani’s, MD, discussion on treatment options.

Koster then returned for a talk on integrating patient care.

Warrington then closed out the webinar with a discussion on novel therapies.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Investigating Brensocatib, Potential First Treatment for Bronchiectasis, with James Chalmers, MBChB, PhD
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
AI in Dermatology: Emerging Insights and Diverging Perspectives
Skin of Color Savvy: News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities
Medical Sisterhood: James Del Rosso, DO
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Brian Lee, MD | Credit: AASLD
© 2025 MJH Life Sciences

All rights reserved.